A Randomized Controlled Trial to Provide Adherence Information and Motivational Interviewing to Improve Diabetes and Lipid Control. (February 2015)

• Record Type: Journal Article
• Authors: Pladevall, Manel; Divine, George; Wells, Karen E.; Resnicow, Ken; Williams, L. Keoki
• Is Part Of: Diabetes educator. Volume 41:Number 1(2015:Feb.)
• Page Start: 136
• Page End: 146
• Publication Date: 2015-02
• Subjects: Diabetes -- Study and teaching -- Periodicals; 616.462005
• DOI: 10.1177/0145721714561031
• Languages: English
• ISSNs: 0145-7217

Abstract

Purpose: The purpose of this study was to assess whether providing medication adherence information with or without motivational interviewing improves diabetes and lipid control. Methods: Study participants were adult members of a health system in southeast Michigan, were using both oral diabetes and lipid-lowering medications, and had glycated hemoglobin (A1C) or low-density lipoprotein cholesterol (LDL-C) levels not at goal. Participants were randomly assigned to receive usual care (UC), n = 567; have medication adherence information (AI) provided to their physician, n = 569; or have AI and receive motivational interviewing (MI) though trained staff (AI + MI), n = 556. Primary outcomes were A1C and LDL-C levels at 18 months post randomization. Results: Primary outcomes were not significantly different between patients in the AI or AI + MI study arms when compared with UC. Similarly, neither oral diabetes nor lipid-lowering medication adherence was significantly different between groups. Patient participation in the AI + MI arm was low and limit the interpretation of the study results, but post hoc analysis of the AI + MI study arm showed that the number of MI sessions received was positively associated with only oral diabetes medication adherence. Conclusion: Neither AI nor MI significantly improved diabetes and lipid control when compared with UC. Moreover, patient participation appeared to be a particular barrier for MI.